Additional information
| Active substance | Memantine |
|---|---|
| Classification | NMDA Receptor Antagonists |
| Water Retention | No significant impact |
| Hepatotoxicity | Low risk |
| Lab Test | Not standard in sports or routine medical testing |
| Also known as | Axura, Ebixa, Memox, Adaxor |
| WAREHOUSE | International Warehouse 1 |
| Blood pressure | Can cause slight increase in blood pressure |
| Trade name | Namenda |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 1-amino-3,5-dimethyladamantane |
| Formula | C12H21N |
| Substance class | NMDA receptor antagonist |
| Main action | Reduces abnormal activity in the brain |
| Half-life | 60-100 hours |
| Dosage (medical) | Usually starts at 5 mg once daily, increasing to 10 mg twice daily as tolerated |
| Dosage (sports) | Not recommended for sports enhancement |
| Effects | Improves memory, awareness, and the ability to perform daily activities |
| Side effects | Dizziness, headache, confusion, hypertension |
| Use in sports | None |
| Manufacturer | Sun Pharma |

EPO 3000iu GENERIC
Seretide Disckus (Advair) 500 mcg Glaxosmithkline
FACTIVE 320 mg Abdi Ibragim
Norvacs 10 mg Pfizer
Januvia 100mg Merckgroup
Champix 56 tabs Pfizer 

Reviews
There are no reviews yet.